ISSN: 1859 - 2872
Screening for critical congenital heart disease in newborns with pulse oximetry
Main Article Content
Keywords
Abstract
Congenital heart disease (CHD) is the most common birth defect in children, about 8 per 1000 live births will have one of the forms of CHD. About 1 in every 4 babies born with a heart defect has a critical congenital heart disease - CCHD (require surgery or other procedures in the first year of life), corresponding to about 18 per 10000 live births born with CCHD [2]. CCHD is not always found obvious signs or symptoms in a newborn, so if the baby is not detected CCHD while the baby is in the neonatal room before going home, it can lead to serious conditions: Cardiac shock or death, survived babies are at risk of nervous damage and developmental delay. Newborn screening for CCHD by pulse oximetry can identify babies with these conditions before obvious signs or symptoms of the disease appear and screening is done before the newborn is discharged from the hospital.
Article Details
References
2. Oster M, Lee K, Honein M, Colarusso T et al (2013) Temporal trends in survival for infants with critical congenital heart defects. Pediatrics 131(5): 1502-1508.
3. Dolk H, Loane M, Garne E et al (2011) Congenital heart defects in Europe: Prevalence and perinatal mortality, 2000 to 2005. Circulation 123 (8): 841-849.
4. Kliegman R (2019) Congenital heart disease. Nelson textbook of pediatrics. 21st edition, Philadelphia, Elsevier: 2367-2374. https://moh.gov.vn/chuong-trinh-muc-tieu-quoc-gia/assetpublisher/7ng11f. EWgASC/content/chuong-trinh-ra-soat-benh-tim-bam-sinh-truoc-sinh.
5. Mahle WT, Martin GR, Beekman RH et al (2012) Section on cardiology and cardiac surgery executive committee: Endorsement of health and human services recommendation for pulse oximetry screening for critical congenital heart disease. Pediatrics 129: 190-192.
6. Riede FT, Worner C, Dahnert I (2010) Effectiveness of neonatal pulse oximetry screening for detection of critical congenital heart disease in daily clinical routine: Results from a prospective multicenter study. Eur J. Pediatr 169: 975-981.
7. Hom LA, Martin GR (2014) U.S. international efforts on critical congenital heart disease screening: Can we have a uniform recommendation for Europe? Early Hum Dev 90(2): 11-14.
8. Thangaratinam S, Daniels J Ewer A.K, Zamora J et al (2012) Pulse oximetry screening for critical congenital heart defects in asymptomatic newborn babies: A systematic review and meta-analysis. Lancet 379: 2459-2464.
9. De-Wahl Granelli A, Wennergren M, Sandberg K, Mellander M et al (2009) Impact of pulse oximetry screening on the detection of duct dependent congenital heart disease: A Swedish prospective screening study in 39,821 newborns. BMJ 338: 3037.
10. Ewer AK, Middleton LJ, Furmston AT et al (2011) Pulse oximetry screening for congenital heart defects in newborn infants (PulseOx): A test accuracy study. Lancet 378: 785-794.
11. Martin GR, Ewer AK, Gaviglio A et al (2020) Updated strategies for pulse oximetry screening for critical congenital Heart disease. Pediatrics 146(1): 20191650.
Article Sidebar
